Hanover, MD (December 13, 2021) — Major, Lindsey & Africa (MLA), the world’s leading legal search firm, today announced the placement of Lee Giguere as chief legal officer and secretary at Obsidian Therapeutics, Inc. The search was conducted by partner, Nancy Reiner, in MLA’s In-House Counsel Recruiting group in Boston.
Reporting directly to the chief executive officer, Paul K. Wotton, Lee will manage the legal function and serve as a key member of Obsidian's executive leadership team, playing a critical role in the company’s strategic decision-making. He will provide operational leadership across a wide array of legal, governance and compliance matters.
Obsidian Therapeutics, Inc. is a biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s proprietary cytoDRiVE® technology provides a way to precisely control the timing and level of protein function by using FDA approved small molecules. Obsidian is headquartered in Cambridge, Mass.
“It was a true pleasure to partner with Obsidian Therapeutics on this significant search for their first chief legal officer,” said Nancy Reiner. “Lee’s broad experience and expertise in legal, healthcare compliance and corporate governance for public life science companies, along with his positivity and passion for Obsidian’s important mission made him an ideal candidate for the role.”
Lee most recently served as general counsel and secretary at the biotechnology company Chiasma, Inc., responsible for all legal, compliance and human resource matters. Before joining Chiasma, he spent several years with Karyopharm Therapeutics Inc., an innovation-driven pharmaceutical company, as deputy general counsel, assistant secretary and Boston Scientific Corporation as senior securities and governance counsel. Lee began his legal career as an associate in the business law practice with Goodwin Procter. Lee earned his J.D. from Northeastern University School of Law and his B.S. from Northeastern University.
For media inquiries please contact us at: